References
- Arbyn M, Buntinx F, Van Ranst M, et al (2004). Virologic versus cytologic triage of women with equivocal pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst, 96, 280-93. https://doi.org/10.1093/jnci/djh037
- Bosch F X, Manos MM, Munoz N, et al (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (Ibscc) study group. J Natl Cancer Inst, 87, 796-802. https://doi.org/10.1093/jnci/87.11.796
- Brink AA, Snijders PJ, Meijer CJ, et al (2006). Hpv Testing In Cervical Screening. Best Pract Res Clin Obstet Gynaecol, 20, 253-66. https://doi.org/10.1016/j.bpobgyn.2005.10.009
- Cuzick J, Arbyn M, Sankaranarayanan R, et al (2008). Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine, 10, 29-41.
- Cuzick J, Szarewski A, Cubie H, et al (2003). Management of women who test positive for high-risk types of human papillomavirus: The Hart Study. Lancet, 362, 1871-6. https://doi.org/10.1016/S0140-6736(03)14955-0
- Gustafsson L, Ponten J, Zack M, et al (1997). International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control, 8, 755-63. https://doi.org/10.1023/A:1018435522475
- Kim JJ, Wright TC, Goldie SJ (2002). Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. Jama, 287, 2382-90. https://doi.org/10.1001/jama.287.18.2382
- Kim JJ, Wright TC, Goldie SJ (2005). Cost-effectiveness of human papillomavirus dna testing in The United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst, 97, 888-95. https://doi.org/10.1093/jnci/dji162
- Kinney WK, Manos MM, Hurley LB, et al (1998). Where's the high-grade cervical neoplasia? the importance of minimally abnormal papanicolaou diagnoses. Obstet Gynecol, 91, 973-6. https://doi.org/10.1016/S0029-7844(98)00080-5
- Kulasingam SL, Kim JJ, Lawrence WF, et al (2006). Cost-Effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study. J Natl Cancer Inst, 98, 92-100. https://doi.org/10.1093/jnci/djj009
- Manos MM, Kinney WK, Hurley LB, et al (1999). Identifying women with cervical neoplasia: using human papillomavirus dna testing for equivocal papanicolaou results. JAMA, 281, 1605-10.
- Nanda K, Mccrory DC, Myers ER, et al (2000). Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med, 132, 810-9. https://doi.org/10.7326/0003-4819-132-10-200005160-00009
- Naucler P, Ryd W, Tornberg S, et al (2009). Efficacy of hpv dna testing with cytology triage and/or repeat hpv dna testing in primary cervical cancer screening. J Natl Cancer Inst, 101, 88-99. https://doi.org/10.1093/jnci/djn444
- Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al (1999). Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet, 354, 20-5. https://doi.org/10.1016/S0140-6736(98)12490-X
- Ronco G, Giorgi-Rossi P, Carozzi F, et al (2006). Human papillomavirus testing nd liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol, 7, 547-55. https://doi.org/10.1016/S1470-2045(06)70731-8
- Schiffman M and Solomon D (2003). Findings to date from the ascus-lsil triage study (Alts). Arch Pathol Lab Med, 127, 946-9.
- Solomon D, Schiffman M, Tarone R (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst, 93, 293-9. https://doi.org/10.1093/jnci/93.4.293
- Solomon D, Schiffman M, Tarone R (2002). Ascus lsil triage study (Alts) conclusions reaffirmed: response to a november 2001 commentary. Obstet Gynecol, 99, 671-4. https://doi.org/10.1016/S0029-7844(02)01922-1
Cited by
- Clinical Significance of Atypical Squamous Cells of Undetermined Significance in Detecting Preinvasive Cervical Lesions in Post-Menopausal Turkish Women vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6639
- Acceptability of Self-Sampling HPV Testing Among Thai Women for Cervical Cancer Screening vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7437
- Clinical management of the first ASCUS report in Chile. Prospective single-cohort study vol.133, pp.6, 2015, https://doi.org/10.1590/1516-3180.2014.9142511
- Colposcopy Requirement of Papanicolaou Smear after Atypical Squamous Cells of Undetermined Significance (ASC-US) by Follow-up Protocol in an Urban Gynaecology Clinic, a Retrospective Study in Thailand vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4977
- Multifaceted Usage of HPV Related Tests and Products in the Management of Cervical Cancer - a Review vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2145
- Clinical Significance of Atypical Squamous Cells of Undetermined Significance among Patients Undergoing Cervical Conization vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8145